Carrie Johnston, MD

Highlights

29

4 grants

KP
Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
National Institute of Allergy and Infectious Diseases · 2026–2031 · via Columbia University
P30AI191337-01A1
Co-I
Northeast/ Caribbean AIDS Education and Training Centers - MAI
Health Resources and Services Administration · 2024–2029 · via Columbia University
1 TR7HA53197-01-00
Co-I
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · 2020–2027
UM1AI069419-15
PI
Aging with HIV: Novel Biomarkers of Inflammation and Morbidity
National Institute on Aging · 2021–2027Career· 2 renewals
K23AG072960-05

Completed grants (1)

Co-I
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk
National Heart, Lung, and Blood Institute · 2021–2025
R01HL160392-01

5

1 study

PI
Menopausal Hormone Therapy for Women Living With HIV (HoT)
PHASE4 · National Institute of Allergy & Infectious Diseases · OPEN TO ACCRUAL (as of 2026)
HIV Infection; Menopause
NCT06856174

Completed & closed trials (4)

PI
Giving Standardized Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
PHASE2 · National Institute of Allergy & Infectious Diseases · IRB STUDY CLOSURE (as of 2026)
HIV I Infection
NCT06005610
PI
Improving Physical Ability and Cellular Senescence Elimination in HIV
PHASE2 · National Institute of Allergy & Infectious Diseases · CLOSED TO ACCRUAL (as of 2026)
HIV; Frailty; Prefrail; Aging Problems
NCT07144293
PI
Aging with HIV: Novel Biomarkers of Inflammation and Morbidity
Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
PI
Antibody response to SARS CoV-2 vaccination in pregnant and lactating women and their neonates
Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2022)

NIAID Renews Weill Cornell Medicine Grant for Advancing Prevention and Treatment Research for HIV
December 1, 2020
Weill Cornell Medicine has received a renewal of a prestigious grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to continue cutting-edge clinical research into treating and preventing infection with human immunodeficiency virus (HIV).